Genovyn Appoints Industry Veterans Sammy Bell as Chief Scientific Officer and Jim Edinger as Chief Development Officer to Accelerate AI-Enabled Therapeutic Discovery and Development

📅 04/06/2026 15:00 📰 financialcontent 👁️ 5 lectures 🌍 États-Unis 📂 Science

Leadership appointments fortify Genovyn’s scientific, translational, and development capabilities across its AI-driven platform